Tech Company Financing Transactions
RapidPulse Funding Round
On 9/13/2022, RapidPulse raised $10.5 million in funding from Sante Ventures, Syntheon and Broadview Ventures.
Transaction Overview
Company Name
Announced On
9/13/2022
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Undisclosed
Investors
Sante Ventures (Lead Investor) (Dennis McWilliams)
Syntheon (Lead Investor) (Sean McBrayer)
Proceeds Purpose
RapidPulse plans to use the proceeds to further advance its RapidPulse Cyclic Aspiration System through expanded clinical evaluation, which in turn will further the development of its platform of new catheters and aspiration pump, and to move towards FDA approval.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
13755 SW 119th Ave.
Miami, FL 33186
USA
Miami, FL 33186
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean McBrayer
Chief Operating Officer
Carlos Rivera
VP - Finance
Carolyn Prieto
VP - Product Management
Heather Harries
VP - R & D
Derek Deville
VP - Regulatory Affairs
Cynthia Yang
Browse more venture capital transactions:
Prev: 9/13/2022: Novome Biotechnologies venture capital transaction
Next: 9/13/2022: Flavrs venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs